بوابة الشروق
Source: بوابة الشروق
24 Hrsبوابة الشروق
Source: بوابة الشروق
24 HrsReady to play
Ready to play
The Egyptian Drug Authority confirmed that there are no decisions to halt the import or circulation of any type of insulin in the Egyptian market. It also pointed out that all necessary products, whether local or imported, are available. The head of the authority explained that 90% of the insulin in circulation comes from trusted international sources, and that Egyptian manufacturers fully meet the demand, producing one million vials monthly for the public sector and 600,000 for the private sector. The authority also emphasized that all medicines are subject to the same oversight and quality standards. The increased reliance on local production aims to strengthen domestic manufacturing while maintaining a variety of alternatives and high quality, ensuring the continued availability of essential medications for patients.
Notice: This Is an AI-Generated Summary
Comments (0)